Recapitalization Services
Our experienced senior bankers provide expert recapitalization advisory and execution services to health sciences firms and investors seeking to optimize their capital structure.
![What We Do - Recap1](https://www.crosstreecapital.com/hubfs/theme-crosstree/images/What%20We%20Do%20-%20Recap1.jpg)
Expertise from a team you can trust
Our Recapitalization services redefine your business's financial landscape, providing a robust foundation for future growth. With a keen understanding of market dynamics, we tailor comprehensive recapitalization strategies to optimize your capital structure.
Whether you're seeking to enhance liquidity, reduce debt burdens, or fuel expansion initiatives, our industry-focused professionals guide you through a seamless process. Trust us to navigate the complexities of recapitalization, ensuring your business not only survives but thrives in today's dynamic economy.
Latest Recapitalization Transactions
![OpenClinica Completes Growth Recapitalization with Thompson Street Capital Partners to Accelerate Enablement of Clinical Trials](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/OpenClinica-v2_2019-MMD-ICON.png)
OpenClinica Completes Growth Recapitalization with Thompson Street Capital Partners to Accelerate Enablement of Clinical Trials
![RealTime Software Solutions Receives Strategic Investment from LLR Partners to Accelerate Growth and Product Innovation](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/RealTime-LLR-Partners_2019-MMD-ICON.jpg)
RealTime Software Solutions Receives Strategic Investment from LLR Partners to Accelerate Growth and Product Innovation
![UpStream Completes $45 Million Funding Round Led by Dragoneer to Revolutionize Care for Older Adults](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/UpStream-Dragoneer-2.jpg)
UpStream Completes $45 Million Funding Round Led by Dragoneer to Revolutionize Care for Older Adults
![WIRB-Copernicus Group (“WCG”) recapitalizes, led by Leonard Green & Partners, L.P.](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/WCG_LGP_2020.png)
WIRB-Copernicus Group (“WCG”) recapitalizes, led by Leonard Green & Partners, L.P.
![Chonometriq Received an Investment from Full In Partners October 1, 2019](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Chronometriq_2019Full-In_2019-Chronometriq-Full-In.png)
Chonometriq Received an Investment from Full In Partners October 1, 2019
![Biorasi Received a Majority Investment from Riordan, Lewis & Haden Equity Partners November 16, 2018](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/2018-BioRasi-RLH@2x.png)
Biorasi Received a Majority Investment from Riordan, Lewis & Haden Equity Partners November 16, 2018
![OmniSeq Received a Strategic Investment from HITACHI April 12, 2018](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/2018-OmniSeq-Hitachi@2x-1.png)
OmniSeq Received a Strategic Investment from HITACHI April 12, 2018
![OmniSeq Received a Strategic Investment from LabCorp August 21, 2017](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/2017-OmniSeq-LabCorp@2x.png)
OmniSeq Received a Strategic Investment from LabCorp August 21, 2017
![Chemical Computing Group Received a Majority Investment from Altaris June 8, 2017](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/2017-ChemicalComputing-ALtaris@2x.png)
Chemical Computing Group Received a Majority Investment from Altaris June 8, 2017
![Medsphere Raised $12,000,000 of Senior Debt](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/2016-MedSphere@2x.png)
Medsphere Raised $12,000,000 of Senior Debt
![NaviNet Amount Raised Undisclosed, Senior Debt by a Placement Agent](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/2014-NaviNet@2x.png)
NaviNet Amount Raised Undisclosed, Senior Debt by a Placement Agent
![ePharmaSolutions Received a Strategic Investment from Arsenal Capital Partners and WIRB-Copernicus Group September 24, 2014](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/2014-Epharma-WCG@2x.png)
ePharmaSolutions Received a Strategic Investment from Arsenal Capital Partners and WIRB-Copernicus Group September 24, 2014
![Endpoint received a strategic investment from Chiltern March 31, 2010](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/2010-EndPoint-Chiltern@2x.png)
Endpoint received a strategic investment from Chiltern March 31, 2010
![Micronics raised $6M in Series B Preferred Shares October 16, 2008](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/2008-Micronics@2x.png)
Micronics raised $6M in Series B Preferred Shares October 16, 2008
![Scandius Biomedical amount raised undisclosed preferred Equity Placement Agent](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/2007-Scandius@2x.png)
Scandius Biomedical amount raised undisclosed preferred Equity Placement Agent
![Gentiae Raised $16M in Series B Preferred Shares from Bay City Capital and CIBC January 3, 2007](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/2006-Gentiae-BayCIty@2x.png)
Gentiae Raised $16M in Series B Preferred Shares from Bay City Capital and CIBC January 3, 2007
![Romark Laboratories Amount Raised Undisclosed](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/2006-Romark@2x.png)
Romark Laboratories Amount Raised Undisclosed
![Bridge Laboratories Raised $35M in Series B Preferred Shares from Aisling Capital and Lehman Brothers June 14, 2006](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/2006-May-BridgeLab-Aisling.png)
Bridge Laboratories Raised $35M in Series B Preferred Shares from Aisling Capital and Lehman Brothers June 14, 2006
![Ixion Biotechnology Inc. Financial advisory](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/2006-Romark@2x.png)
Ixion Biotechnology Inc. Financial advisory
![PBI Financial Advisory](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/2005-DigitalHealthcare@2x.png)